相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Activation, dysfunction and retention of T cells in vaccine sites after injection of incomplete Freund's adjuvant, with or without peptide
Elise P. Salerno et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2013)
A Randomized Phase II Trial of Multiepitope Vaccination with Melanoma Peptides for Cytotoxic T Cells and Helper T Cells for Patients with Metastatic Melanoma (E1602)
Craig L. Slingluff et al.
CLINICAL CANCER RESEARCH (2013)
At the Bedside: CTLA-4-and PD-1-blocking antibodies in cancer immunotherapy
Margaret K. Callahan et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2013)
Persistent antigen at vaccination sites induces tumor-specific CD8+ T cell sequestration, dysfunction and deletion
Yared Hailemichael et al.
NATURE MEDICINE (2013)
Predicting the efficacy of cancer vaccines by evaluating T-cell responses
Suzanne van Duikeren et al.
ONCOIMMUNOLOGY (2013)
Recombinant IgE antibodies for passive immunotherapy of solid tumours: from concept towards clinical application
Sophia N. Karagiannis et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2012)
Vaccine-Induced Effector-Memory CD8+ T Cell Responses Predict Therapeutic Efficacy against Tumors
Suzanne van Duikeren et al.
JOURNAL OF IMMUNOLOGY (2012)
Molecular Insights on the Peripheral and Intratumoral Effects of Systemic High-Dose rIL-2 (Aldesleukin) Administration for the Treatment of Metastatic Melanoma
Geoffrey R. Weiss et al.
CLINICAL CANCER RESEARCH (2011)
Randomized Multicenter Trial of the Effects of Melanoma-Associated Helper Peptides and Cyclophosphamide on the Immunogenicity of a Multipeptide Melanoma Vaccine
Craig L. Slingluff et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
gp100 Peptide Vaccine and Interleukin-2 in Patients with Advanced Melanoma
Douglas J. Schwartzentruber et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Novel cancer immunotherapy agents with survival benefit: recent successes and next steps
Padmanee Sharma et al.
NATURE REVIEWS CANCER (2011)
Immunogenicity for CD8+ and CD4+ T Cells of 2 Formulations of an Incomplete Freund's Adjuvant for Multipeptide Melanoma Vaccines
Craig L. Slingluff et al.
JOURNAL OF IMMUNOTHERAPY (2010)
Kinetics of Serum Cytokines after Primary or Repeat Vaccination with the Smallpox Vaccine
Jeffrey I. Cohen et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
Dynamic changes in cellular infiltrates with repeated cutaneous vaccination: a histologic and immunophenotypic analysis
Jochen T. Schaefer et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2010)
Ipilimumab monotherapy in patients with pretreated advanced melanoma: a randomised, double-blind, multicentre, phase 2, dose-ranging study
Jedd D. Wolchok et al.
LANCET ONCOLOGY (2010)
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
F. Stephen Hodi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Effect of Granulocyte/Macrophage Colony-Stimulating Factor on Circulating CD8+ and CD4+ T-Cell Responses to a Multipeptide Melanoma Vaccine: Outcome of a Multicenter Randomized Trial
Craig L. Slingluff et al.
CLINICAL CANCER RESEARCH (2009)
Sequential administration of GM-CSF (Sargramostim®) and IL-2 ± autologous vaccine as adjuvant therapy in cutaneous melanoma:: An interim report of a phase II clinical trial
E. George Elias et al.
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS (2008)
Helper T-Cell Responses and Clinical Activity of a Melanoma Vaccine With Multiple Peptides From MAGE and Melanocytic Differentiation Antigens
Craig L. Slingluff et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Cytokine and chemokine profiles following vaccination with human papillomavirus type 16 L1 virus-like particles
Alfonso Garcia-Pineres et al.
CLINICAL AND VACCINE IMMUNOLOGY (2007)
Th2-associated local reactions to the acellular diphtheria-tetanus-pertussis vaccine in 4-to 6-year-old children
J Rowe et al.
INFECTION AND IMMUNITY (2005)
Melanoma recurrence patterns after negative sentinel lymphadenectomy
TG Zogakis et al.
ARCHIVES OF SURGERY (2005)
Autoimmune toxicities associated with the administration of antitumor vaccines and low-dose interleukin-2
KA Chianese-Bullock et al.
JOURNAL OF IMMUNOTHERAPY (2005)
Adverse events after smallpox immunizations are associated with alterations in systemic cytokine levels
MT Rock et al.
JOURNAL OF INFECTIOUS DISEASES (2004)
Assessment of the toxicities of systemic low-dose interleukin-2 administered in conjunction with a melanoma peptide vaccine
EMH Woodson et al.
JOURNAL OF IMMUNOTHERAPY (2004)
Immunologic and clinical outcomes of vaccination with a multiepitope melanoma peptide vaccine plus low-dose interleukin-2 administered either concurrently or on a delayed schedule
CL Slingluff et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Combination chemotherapy with or without s.c. IL-2 and IFN-α:: results of a prospectively randomized trial of the Cooperative Advanced Malignant Melanoma Chemoimmunotherapy Group (ACIMM)
J Atzpodien et al.
BRITISH JOURNAL OF CANCER (2002)
分享论文
